申请人:USV PHARMACEUTICAL CORPORATION
公开号:EP0054936A1
公开(公告)日:1982-06-30
This invention relates to new chemical compounds possessing valuable pharmaceutical activity. It particularly relates to compounds possessing antihypertensive and angiotensin converting enzyme inhibitory activity and having the structure:
wherein:
Q is oxygen, sulfur or NH;
X and Y are hydrogen, halogen, hydroxy, alkoxy,
trifluoromethyl, nitro, carboxy, cyano, sulfonamido,
sulfhydryl, alkyl, alkenyl, alkynyl, alkanoyl, alkylmercapto, amino, alkylamino, dialkylamino, alkylsulfinyl, and alkylsulfonyl and may be the same or different;
R, is hydrogen, alkanoyl, substituted alkanoyl wherein the substituent is hydroxy, amino or cycloalkyl, aroyl, arylakanoyl, or cycloalkylcarbonyl,
n is an integer from to 4 inclusive,
R2 and R3 are hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, and substituted derivatives thereof wherein the substituents are hydroxy, amino, alkylamino, dialkylamino, alkoxy, halogen, hydroxy, mercapto, alkylmercapto and nitro, and may be the same or different;
M is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, and hetero; and Z is hydroxy, amino, alkylamino, dialkylamino, or alkoxy; and non-toxic pharmaceutically-acceptable salts of the said compounds.
本发明涉及具有宝贵药物活性的新化合物。它特别涉及具有抗高血压和血管紧张素转换酶抑制活性并具有以下结构的化合物:
其中
Q 是氧、硫或 NH;
X和Y是氢、卤素、羟基、烷氧基
X和Y是氢、卤素、羟基、烷氧基、三氟甲基、硝基、羧基、氰基、磺酰氨基
巯基、烷基、烯基、炔基、烷酰基、烷基巯基、氨基、烷基氨基、二烷基氨基、 烷基亚磺酰基和烷基磺酰基,可以相同或不同;
R,是氢、烷酰基、取代基为羟基、氨基或环烷基、芳基、芳基烷酰基或环烷基羰基的取代烷酰基、
n 为 4(含 4)以下的整数、
R2 和 R3 为氢、烷基、烯基、炔基、环烷基、环烷基-烷基、芳基、芳烷基及其取代衍生物,其中取代基为羟基、氨基、烷基氨基、二烷基氨基、烷氧基、卤素、羟基、巯基、烷基巯基和硝基,可以相同或不同;
M 是烷基、烯基、炔基、环烷基、环烷基-烷基、芳基、芳烷基和杂基;Z 是羟基、氨基、烷基氨基、二烷基氨基或烷氧基;以及上述化合物的无毒药学上可接受的盐。